Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Exsalta

K-Number: K221676 · 2022-09-16

ApplicantDrw Medical
Decision Date2022-09-16
Product CodeBTA
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Exsalta is a medical device manufactured by Drw Medical. It received FDA 510(k) clearance on 2022-09-16 under approval number K221676. The device is classified under product code BTA. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Exsalta?

Exsalta is a medical device that received FDA 510(k) clearance on 2022-09-16. It is manufactured by Drw Medical. The 510(k) number is K221676.

When was Exsalta approved by the FDA?

Exsalta received FDA 510(k) clearance on 2022-09-16, under approval number K221676.

What company makes Exsalta?

Exsalta is manufactured by Drw Medical.

What is the FDA product code for Exsalta?

The FDA product code for Exsalta is BTA.

Related Devices (Code: BTA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.